People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Other, Pharmaceuticals, Manufacturing, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omega Holdco II Ltd | — | Other | Growth/Late | $551.3M | $9.8B | 2015 |
| Eliem Therapeutics, Inc. | — | Pharmaceuticals | Series D+ | $253.2M | $1.3B | 2024 |
| BCPE INCR Holdings, Inc. | — | Manufacturing | Series B | $16.6M | $182.3M | 2017 |
| Hack Notice, Inc. | — | Other Technology | Series A | $6.4M | $83.4M | 2022 |
| Streamroot, Inc. | — | Other Technology | Seed | $4.6M | $85.2M | 2017 |
Stephen Thomas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Thomas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 1 | 17 |
| Adam Rosenberg | 1 | 6 |
| Liam Ratcliffe | 1 | 4 |
| Erin Lavelle | 1 | 3 |
| Carol S. Eicher | 1 | 3 |
| Julio Vega | 1 | 3 |
| David-Alexandre Gros | 1 | 2 |
| Todd Cook | 1 | 2 |
| Chris Ahern | 1 | 2 |
| Robert Azelby | 1 | 2 |
| Aoife Brennan | 1 | 2 |
| SANDRA D. OLISZEWICZ | 1 | 1 |
| ADAM NEBESAR | 1 | 1 |
| DOUG S. VAUGHAN | 1 | 1 |
| JOSH S. BEKENSTEIN | 1 | 1 |
| STEVEN ZIDE | 1 | 1 |
| TIMOTHY KNUTSON | 1 | 1 |
| PAUL EDGERLEY | 1 | 1 |
| WILLIAM KOZYRA | 1 | 1 |
| Nikolay Rodionov | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.